Cannabinoids lessen pain from sickle cell disease (SCD) as well as opioids, at least in a mouse model, according to a new study at the University of Minnesota Medical School. The novel approach seems to provide relief similar to opioids, the current standard of care, for acute and chronic pain. However, cannabinoids have fewer negative side effects since smaller doses are required to achieve relief, decreasing the amount of drug reacting in the brain. [Read Article]

• Rituximab effective in treating vasculitus [+]
• Researchers claim gene therapy corrects β-thalassemia [+]
• UCB transplant is viable option for adult acute leukemia [+]
• Patient advocacy in clinical trials [+]
• EZH2 in MPNs and MDS [+]
• New drug active across subtypes of DLBCL [+]
• VMPT emerges as new standard for older MM patients [+]
• New agent active in relapsed/refractory malignancies [+]